Bax, Bridget E <br/><br/>
A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.  [electronic resource] 

 -  European journal of haematology  Oct 2007 
 - 338-48 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0902-4441 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0609.2007.00927.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Deaminase--administration & dosage<br/>Adenosylhomocysteinase--immunology<br/>Adult<br/>Antigens, CD20--blood<br/>Autoantibodies--blood<br/>Deoxyadenine Nucleotides--immunology<br/>Enzymes, Immobilized--administration & dosage<br/>Erythrocytes--enzymology<br/>Female<br/>Forced Expiratory Flow Rates--drug effects<br/>Humans<br/>Immunoglobulin G--blood<br/>Lung Diseases--enzymology<br/>Lymphocyte Count<br/>Polyethylene Glycols--administration & dosage<br/>Severe Combined Immunodeficiency--drug therapy<br/>Time Factors